CUMBERLAND PHARMACEUTICALS INC Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Cumberland Pharmaceuticals Inc quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q2 2024.
  • Cumberland Pharmaceuticals Inc Other Assets, Noncurrent for the quarter ending June 30, 2024 was $2.99M, a 14.8% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.99M +$387K +14.8% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $3.06M +$515K +20.2% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $2.69M +$172K +6.83% Dec 31, 2023 10-Q 2024-08-09
Q3 2023 $2.56M +$129K +5.3% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $2.61M +$70.6K +2.78% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $2.55M -$633K -19.9% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $2.52M -$899K -26.3% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $2.43M -$875K -26.5% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $2.54M -$954K -27.3% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $3.18M -$145K -4.36% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $3.42M +$186K +5.74% Dec 31, 2021 10-K 2023-03-13
Q3 2021 $3.3M +$790K +31.4% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $3.49M +$552K +18.8% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $3.32M +$686K +26% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $3.23M -$64.4K -1.95% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $2.51M -$3.82M -60.3% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $2.94M -$3.13M -51.5% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $2.64M -$3.57M -57.5% Mar 31, 2020 10-Q 2020-05-22
Q4 2019 $3.3M +$767K +30.3% Dec 31, 2019 10-K 2021-03-12
Q3 2019 $6.33M +$3.52M +125% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $6.07M +$3.52M +138% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $6.21M +$3.64M +142% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $2.53M +$44.5K +1.79% Dec 31, 2018 8-K 2020-12-10
Q3 2018 $2.81M +$556K +24.7% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $2.55M +$345K +15.7% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $2.57M +$401K +18.5% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $2.49M +$366K +17.3% Dec 31, 2017 10-K 2019-03-12
Q3 2017 $2.25M -$203K -8.26% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $2.2M -$308K -12.3% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $2.16M -$532K -19.7% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $2.12M +$230K +12.1% Dec 31, 2016 10-K 2018-03-09
Q3 2016 $2.46M -$117K -4.53% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $2.51M +$123K +5.15% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $2.7M +$288K +12% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 $1.89M +$99.1K +5.53% Dec 31, 2015 10-K 2017-03-13
Q3 2015 $2.57M -$453K -15% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $2.39M -$649K -21.4% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $2.41M -$149K -5.82% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 $1.79M +$446K +33.2% Dec 31, 2014 10-K 2016-03-14
Q3 2014 $3.03M +$1.6M +112% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $3.04M +$1.72M +130% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 $2.56M +$1.86M +265% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $1.35M +$700K +109% Dec 31, 2013 10-K 2015-03-09
Q3 2013 $1.43M +$776K +119% Sep 30, 2013 10-Q 2013-11-06
Q2 2013 $1.32M +$669K +103% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $700K +$637K +1003% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $645K +$578K +851% Dec 31, 2012 10-K 2014-03-11
Q3 2012 $654K -$1.32M -66.9% Sep 30, 2012 10-Q 2012-11-02
Q2 2012 $650K -$1.27M -66.2% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $63.5K Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $67.8K -$34.9K -34% Dec 31, 2011 10-K 2013-03-12
Q3 2011 $1.97M Sep 30, 2011 10-Q 2011-11-07
Q2 2011 $1.92M Jun 30, 2011 10-Q 2011-08-08
Q4 2010 $103K Dec 31, 2010 10-K 2012-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.